Colmar, PA – April 15, 2020 – Biological Specialty Company (BSC), a BioIVT company, has launched an at-home blood donation service for COVID-19 positive patients. Blood donations are urgently required from patients who are sick with or have recovered from COVID-19 to help develop new therapies, vaccines and diagnostic biomarkers for the disease.
News
Oxford, UK, 15th April 2020 / Sciad Newswire / The Covid-19 Volunteer Testing Network launched on 1st April 2020 to provide essential additional testing capacity to front-line workers. The project, started by Mike Fischer CBE, helps small laboratories convert to run critical antigen testing and identify Covid-19 cases among local healthcare workers - at no cost to Government.
Responding to an increase in demand for its expert regulatory services, leading pharmaceutical and biotech product development consultancy Boyds has made two key hires to its Regulatory Affairs team.
Dr Victoria Marsh joins the company as Director of Regulatory Affairs and Dr Kim Champion as Regulatory Affairs Manager.
Cambridge UK – 15 April 2020 – Healx, the AI-powered and patient-inspired tech company specialising in accelerating the discovery and development of rare disease treatments, today announced a partnership with US and Europe-based patient group Children’s Tumor Foundation (CTF) to progress new AI-derived therapies for neurofibromatosis (NF).
Cambridge, UK, 14 April 2020: Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Company” or “the Group”), a global leader in the application of gene editing and gene modulation for cell line engineering, today announced special commercial licensing terms to facilitate rapid access to its cGMP-compliant CHOSOURCE™ platform for the development or production of therapeutic proteins, diagnostic assay components or vaccines relating to COVID-19.
Applications for Accelerate@Babraham, designed to support early stage life science ventures, will close on June 17th 2020.
The Accelerate@Babraham initiative is designed to support ambitious early stage life science ventures. It does this by giving access to appropriate short-term open access laboratory and office space, facilitating interaction with the academic community at the Babraham Institute and providing access to our global network, including mentoring and business support.
Hints and Tips for Working from Home by george james ltd
Working from home is a new experience for many people, and even those of us who have worked at home on and off for many years have probably not done so for such an extended period. For some people working at home may become the new norm.
george james ltd have put together some hints and tips that we hope you find helpful.
Cambridge, UK: 14 April 2020: Kymab, a clinical-stage biopharmaceutical company developing fully human monoclonal antibody therapeutics, announces that Regeneron Pharmaceuticals Inc (“Regeneron”) has been unsuccessful in recent attempts to invalidate four of Kymab’s US patents covering genetically modified mice and the human antibody therapeutics produced from these mice. The patents are US patent numbers 9,434,782; 9,505,827; 9,447,177; and 10,165,763 known as the “Bradley Patents”.
New England Biolabs is working diligently to ensure we keep our employees and their families safe, while maintaining our business continuity in support of our many customers around the globe. Our manufacturing and distribution teams continue to be fully operational, and we are working closely with our suppliers and distribution partners to ensure uninterrupted access to our products and technical support. We are also following the guidelines of local and national health organizations in order to mitigate the spread of COVID-19.
The MagSi-NA Pathogens Kit from AMSBIO enables easy extraction of DNA and RNA from serum, plasma, oropharyngeal swab / nasopharyngeal swab, and any other respiratory samples for pathogen detection.
The kit is particularly suitable for total nucleic acid extraction for SARS-CoV-2 / COVID-19 detection, currently a major bottleneck in COVID-19 testing.